DJIA 16,828.87 52.44 0.31%
NASDAQ 4,753.79 -27.47 -0.57%
S&P 500 1,983.16 -3.89 -0.20%
market minute promo

Gilead Sciences (NASDAQ: GILD)

97.59 -1.68 (-1.69%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GILD $97.60 -1.67%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $98.82
Previous Close $99.26
Daily Range $95.05 - $98.90
52-Week Range $85.95 - $123.37
Market Cap $143.2B
P/E Ratio 10.44
Dividend (Yield) $1.72 (1.7%)
Ex-Dividend Date
Dividend Pay Date
Volume 11,420,410
Average Daily Volume 13,304,447
Current FY EPS $11.99




Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary Rss Feed

Why AbbVie Inc.'s Shares Slumped 13% in September

Risk of patent expiration on Humira and Gilead Sciences positive hepatitis C trial results weighed on shares last month.

3 Biotech Stocks That Have Been Unfairly Beaten Down

Biotech stocks have been under attack recently, but which names have fallen the hardest for reasons that have nothing to do with the companies' performance?

'Fast Money' Recap: Have Markets Risen Too Far Too Fast?

Gilead's Letairis Gets FDA Nod in Combination with Adcirca

Tweet This Hillary: Pros See Biotech ETFs As A Buy

ContraVir Soars 150% as New HBV Drug is 60x More Active than Gilead's Viread

Health Care Sector Update for 10/05/2015: ONCE,CTRV,SIEN

Biotech Returns Outstanding Even Given Recent Weakness

Strong Upward Pre-Market Activity For Gilead (GILD)

3 Biotech Bargains to Buy

With biotech stocks tumbling, one Fool points out three top stocks in the industry to buy for the long-haul.

See More GILD News...

GILD's Top Competitors

GILD $97.59 (-1.69%)
Current stock: GILD
CELG $112.20 (-3.79%)
Current stock: CELG
BIIB $276.53 (-3.50%)
Current stock: BIIB
AMGN $141.65 (-1.50%)
Current stock: AMGN